Drawing for ZIP DIAGNOSTICS

USPTO serial 79326971

ZIP DIAGNOSTICS

Reviewed by CopyMark Law Group

Reg. 8131479Status 700Registered
Filing date
Status date
Registration date
Feb 10, 2026
Examiner
SWAIN, MICHELE LYNN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ZIP DIAGNOSTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jason Paul Blair

Jason Paul Blair Neal & McDevitt, LLC2801 Lakeside Drive, Suite 201Bannockburn, IL 60015United States

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware and peripheral devices; computer hardware devices for monitoring, measuring, testing, sensing, or diagnosing infectious diseases, genomic variants, or antigens, and for recording, storing, and displaying information and results related thereto; recorded or downloadable computer software for monitoring, measuring, testing, sensing, or diagnosing infectious diseases, genomic variants, or antigens, and for recording, storing, and displaying information and results related thereto; computer hardware with preinstalled recorded operating system software for monitoring, measuring, testing, sensing, or diagnosing infectious diseases, genomic variants, or antigens, and for recording, storing, and displaying information and results related thereto; data communications instruments; diagnostic testing instruments for use in immunoassay procedure, other than for medical purposes; electronic image processing, recording, or digitizing apparatus; instruments for use in liquid or gas chromatography for scientific use; portable instruments, namely, monitors and sensors for monitoring oxygen levels in gaseous mixtures other than medical use; scientific laboratory research instruments for the detection of pathogens, infectious diseases, genomic variants or antigens in a biological sample for research use; laboratory swabs; scientific laboratory research apparatus and instruments for screening for infectious diseases and pathogensACTIVE—
010Medical diagnostic apparatus for testing for infectious diseases; medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic instruments for the analysis of body fluids; nuclear medicine diagnostic imaging apparatus; sample preparation devices for medical diagnostic uses; medical instruments for testing cardiovascular disease; portable medical instruments for monitoring oxygen levels in gaseous mixtures for medical use; temperature measuring instruments, namely, thermometers for medical use; diagnostic apparatus for testing for specific DNA, pathogens, antigens, viruses and bacteria for medical use; instruments for testing microbiological samples for medical use; gas chromatography apparatus for medical use; none of the aforementioned related to sutures or skin closure devicesACTIVE—
040Custom manufacture of scientific and medical devices for analysis of fluids and other materials; custom manufacture of medical devices; custom manufacture of medical devices including microfluidic devices, medical cartridges; information, advisory and consultancy services in relation to the aforementionedACTIVE—
042Design of instruments; scientific research services; design and development of computer hardware and software; design of chips used for scientific purposes; custom design of chips for scientific purposes, including chips for scientific analysis of fluids and other materials; scientific project management services in the field of scientific research and analysis; design and development of consumer products; design and development of biotech laboratory, research, and diagnostic products and tests for scientific purposes; process engineering for scientific purposes; laboratory research and research laboratory analysis in the fields of biochemistry, infectious diseases, molecular diagnostics, protein variants, chemical assays, and genomic variants; information, advisory and consultancy services in relation to the aforementionedACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 13, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 12, 2026FIMPFINAL DISPOSITION PROCESSED—
May 10, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 10, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 10, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 23, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 23, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 17, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 11, 2025GPNXNOTIFICATION PROCESSED BY IB—
Nov 26, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 25, 2025OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 25, 2025PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Oct 30, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 3, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 1, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 1, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 1, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 1, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 1, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 3, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 13, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 2, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 17, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 22, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 3, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 3, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 12, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 5, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 5, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Dec 5, 2022CNSLSUSPENSION LETTER WRITTEN—
Nov 10, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 9, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 9, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2022RFNTREFUSAL PROCESSED BY IB—
May 12, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 12, 2022RFRRREFUSAL PROCESSED BY MPU—
May 12, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 11, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2022DOCKASSIGNED TO EXAMINER—
Dec 7, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 3, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 2, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance